Management of dyspnea in interstitial lung disease.

TitleManagement of dyspnea in interstitial lung disease.
Publication TypeJournal Article
Year of Publication2010
AuthorsRyerson, CJ, Collard, HR, Pantilat, SZ
JournalCurr Opin Support Palliat Care
Volume4
Issue2
Pagination69-75
Date Published2010 Jun
ISSN1751-4266
KeywordsActivities of Daily Living, Dyspnea, Exercise Therapy, Humans, Lung Diseases, Interstitial, Pulmonary Gas Exchange, Quality of Life
Abstract

PURPOSE OF REVIEW: Dyspnea is the most common symptom in interstitial lung disease, yet little is known about its management. This review summarizes the available evidence for the treatment of dyspnea in interstitial lung disease.RECENT FINDINGS: The management of dyspnea in interstitial lung disease remains a challenge, with few effective therapies. Limited evidence suggests that pulmonary rehabilitation is an effective treatment of dyspnea. In patients with interstitial lung disease, dyspnea severity is associated with measures of ventilatory restriction, gas exchange, functional status, mental health, and some comorbid diseases. Treatment directed toward these modifiable correlates of dyspnea might be effective in dyspnea management; however, the outcome of this strategy has not been adequately studied.SUMMARY: Studies support pulmonary rehabilitation as an effective treatment for dyspnea in interstitial lung disease and pulmonary rehabilitation should be considered in all dyspneic patients. Several investigational agents have been developed and evaluated for potential use in fibrotic interstitial lung disease; however, these agents have not been shown to improve dyspnea.

DOI10.1097/SPC.0b013e3283392b51
Alternate JournalCurr Opin Support Palliat Care
PubMed ID20375900